Safety and tolerability of phage therapy in severe S. aureus infection

An observational, open-label study assessed adjunctive intravenous AB-SA01 phage therapy in 13 critically ill patients with severe Staphylococcus aureus bacteraemia, including six with endocarditis, alongside standard medical and surgical care.